[1]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46-49.[doi:10.3969/j.issn.1006-1959.2022.09.011]
 TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(09):46-49.[doi:10.3969/j.issn.1006-1959.2022.09.011]
点击复制

冠心病介入治疗后再狭窄的中西医防治()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年09期
页码:
46-49
栏目:
综述
出版日期:
2022-05-01

文章信息/Info

Title:
Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine
文章编号:
1006-1959(2022)09-0046-04
作者:
田跃雷
(天津医科大学总医院滨海医院心内科,天津 300480)
Author(s):
TIAN Yue-lei
(Department of Cardiology,Binhai Hospital,General Hospital of Tianjin Medical University,Tianjin 300480,China)
关键词:
冠心病介入治疗再狭窄中西医结合
Keywords:
Coronary heart diseaseInterventional therapyRestenosisCombination of traditional Chinese and western medicine
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2022.09.011
文献标志码:
A
摘要:
冠心病是由于冠状动脉发生粥样硬化病变,造成血管管腔狭窄、阻塞,从而导致心肌因缺血、缺氧、坏死而出现的一种心脏疾病。主要表现为胸前区突发性绞痛,具有病情进展快、病死率及致残率高的特点,严重威胁患者的生命健康。经皮冠状动脉介入治疗(PCI)是临床有效的治疗手段,可缓解心肌缺血、缺氧,减轻临床症状。但是PCI术后仍然存在再狭窄的风险,如何有效防治冠心病介入治疗后再狭窄仍然是临床迫切需要解决的问题之一。本文对冠心病介入治疗后再狭窄发病机制、西医和中医防治进展进行综述,以期为临床预防冠心病介入治疗后再狭窄,确保冠心病介入治疗后的效果提供一定的理论依据。
Abstract:
Coronary heart disease (CHD) is a kind of heart disease, which is caused by coronary artery atherosclerosis, vascular lumen stenosis and obstruction, resulting in myocardial ischemia, hypoxia and necrosis. It is mainly manifested as sudden cramps in the anterior chest region, with the characteristics of rapid progression, high mortality and disability rate, which seriously threaten the life and health of patients. Percutaneous coronary intervention (PCI) is an effective clinical treatment, which can alleviate myocardial ischemia, hypoxia and clinical symptoms. However, there is still a risk of restenosis after PCI. How to effectively prevent and treat restenosis after PCI is still one of the urgent clinical problems. In this paper, the pathogenesis of restenosis after coronary intervention, western medicine and TCM prevention and treatment progress were reviewed, in order to provide a theoretical basis for clinical prevention of restenosis after coronary intervention and ensure the effect of coronary intervention.

参考文献/References:

[1]贾珠银,杨建敏.替格瑞洛联合阿司匹林治疗急性冠状动脉综合征的临床研究[J].中国临床药理学杂志,2016,32(14):1254-1256,1282.[2]李明琰,崔永生,何文凯,等.冠心病患者经皮冠状动脉介入治疗术后规范药物治疗对颈动脉粥样硬化的影响[J].中国医科大学学报,2016,45(1):66-69.[3]吕中华,耿晓雯,程庆强,等.老年与中年急性冠脉综合征患者不同双联抗血小板方案疗效与出血风险比较[J].中华老年多器官疾病杂志,2017,16(3):191-195.[4]刘浙波,夏豪,方钊,等.益心舒胶囊对冠心病经皮冠状动脉介入术后患者发生心血管不良事件的影响[J].广西医学,2016, 38(4):546-548.[5]左祖文,陆超灵,谭剑炼.老年冠心病患者PCI术后发生支架内再狭窄的相关影响因素分析[J].医学临床研究,2018,35(3):449-452.[6]邵晓萍,孙亚召,白春林.尿酸对急性ST段抬高型心肌梗死介入治疗患者远期预后的影响[J].中华老年心脑血管病杂志,2019,21(6):612-614.[7]雷存.中西医结合防治冠心病支架术后再狭窄疗效研究[J].中西医结合心血管病电子杂志,2018,6(7):34-35.[8]贺清明.氯吡格雷对冠心病患者经皮冠状动脉介入术后心血管不良事件的预防效果观察[J].实用心脑肺血管病杂志,2015,23(5):133-135.[9]黄榕翀,袁晨,毋健,等.冠心病合并房颤不同抗栓治疗策略的临床预后分析[J].中国循环杂志,2016,8(1):70.[10]梁颖,黄汉辉,赖天幸,等.紫杉醇药物涂层球囊治疗冠脉支架内再狭窄的临床研究[J].中国医药导报,2018,15(26):43-45.[11]姚远,王甫誉,刘志新,等.血管内皮生长因子和一氧化氮水平对心肌梗死患者冠状动脉支架置入术后再狭窄的预测研究[J].中国临床医生杂志,2018,46(9):1054-1056.[12]李爱霞,罗国帅,曲鹏展,等.骨桥蛋白对药物代谢酶CYP2C9正常代谢型冠心病介入治疗后支架内再狭窄的预测价值[J].心肺血管病杂志,2018,37(10):889-892.[13]唐亮,马露萍.益气活血化瘀汤治疗外周动脉介入术后再狭窄的临床疗效观察及安全性评价[J].世界中西医结合杂志,2017,12(9):1291-1294.[14]胡晓贞,曹振东,王胜林,等.颜氏温阳活血方防治冠状动脉介入术后再狭窄的临床观察[J].上海中医药杂志,2017,51(4):65-68.[15]刘颖芝,熊振宇,熊龙根.冠心病介入术后缬沙坦对冠脉再狭窄的影响[J].中国医药导报,2018,15(22):81-84.[16]杨泽,苟筱雯,赵林华,等.态靶辨证在痰瘀互阻心绞痛中的运用——瓜蒌薤白半夏汤加降香、三七、蜈蚣粉[J].辽宁中医杂志,2021,48(7):1-3.[17]李其周,胡刚,王雨来.冠心通络胶囊联合双联抗血小板药物防治冠心病PCI术后支架内再狭窄34例临床观察[J].中医药导报,2016,22(3):80-82.[18]王颜.加味血府逐瘀汤对冠心病PCI术后再狭窄的干预效果[J].中医药导报,2015,21(17):90-92.[19]代国方,张保珠,王菲.通脉方防治冠脉支架植入术后气虚血瘀型病人再狭窄的临研究[J].中西医结合心脑血管病杂志,2017,15(2):136-142.[20]郭素芬.益气活血法防治PCI术后再狭窄疗效临床观察[J].辽宁中医药大学学报,2017,19(3):196-198.[21]齐锋,宋柏奇.补阳还五汤联合西药常规干预治疗冠心病经皮冠状动脉介入术后不稳定性心绞痛气虚血瘀型39例[J].中医研究,2016,29(9):13-15.[22]黄迎春,马丽荣,刘盼功,等.冠心病PCI 术后应用参七汤对冠脉再狭窄的临床预防干预效果观察[J].世界中医药,2016,11(6):1002-1006.[23]李理,国联军,楚妍峰.瓜蒌皮颗粒剂治疗PCI术后再狭窄软斑块的疗效观察[J].中西医结合心脑血管病杂志2019,17(2):169-172.[24]谭花,刘栋,邱桂华.中医疏肝化瘀法对下肢动脉血管介入术后再狭窄的疗效及对血流动力学影响[J].世界中西医结合杂志,2019,14(12):1747-1749,1756.[25]侯丽芳,首云锋.丹参多酚酸盐注射液对PCI术相关心肌损伤及神经内分泌激素、血管内皮功能及心功能的影响[J].现代中西医结合杂志,2018,27(23):2573-2576.[26]张强.通心络胶囊用于冠心病介入术后患者疗效观察[J].临床合理用药杂志,2020,13(11):1-3.[27]李军英,郭志刚.通心络胶囊对冠心病介入术后患者疗效观察及对血管内皮功能和炎症因子影响[J].中成药,2019,41(5):1202-1204.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
 YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(09):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
 ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(09):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[3]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
 ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(09):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[4]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
 XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(09):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[5]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
 WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(09):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[6]李 铎.β受体阻滞剂预处理对AMI介入治疗患者心室重构、 自主神经功能恢复的影响研究[J].医学信息,2018,31(09):91.[doi:10.3969/j.issn.1006-1959.2018.09.027]
 LI Duo.Effect of β-blocker Preconditioning on Ventricular Remodeling and Autonomic Nerve Function Recovery in Patients Undergoing AMI Intervention[J].Medical Information,2018,31(09):91.[doi:10.3969/j.issn.1006-1959.2018.09.027]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
 MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(09):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
 YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(09):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
 LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(09):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
 GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Medical Information,2018,31(09):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[11]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
 ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[12]何进舟,陈德彬,郭厚玲.介入治疗对冠心病合并左心功能不全患者的心功能 及生活质量的影响[J].医学信息,2019,32(18):78.[doi:10.3969/j.issn.1006-1959.2019.18.024]
 HE Jin-zhou,CHEN De-bin,GUO Hou-ling.Effect of Interventional Therapy on Cardiac Function and Quality of Life in Patients with Coronary Heart Disease Complicated with Left Ventricular Dysfunction[J].Medical Information,2019,32(09):78.[doi:10.3969/j.issn.1006-1959.2019.18.024]
[13]王永智.经皮冠状动脉介入治疗冠心病研究进展[J].医学信息,2019,32(16):41.[doi:10.3969/j.issn.1006-1959.2019.16.013]
 WANG Yong-zhi.Progress in Percutaneous Coronary Intervention for Coronary Heart Disease[J].Medical Information,2019,32(09):41.[doi:10.3969/j.issn.1006-1959.2019.16.013]
[14]杨 骏.延续性自我管理教育对冠心病介入治疗患者生活质量的影响[J].医学信息,2021,34(14):181.[doi:10.3969/j.issn.1006-1959.2021.14.052]
 YANG Jun.The Effect of Continuous Self-management Education on the Quality of Life of Patients with Coronary Heart Disease Interventional Therapy[J].Medical Information,2021,34(09):181.[doi:10.3969/j.issn.1006-1959.2021.14.052]

更新日期/Last Update: 1900-01-01